SM-Youtube

1

Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects.

Valentino LA, Rusen L, Elezovic I, Smith LM, Korth-Bradley JM, Rendo P. Valentino LA, et al. Among authors: elezovic i. Haemophilia. 2014 May;20(3):398-406. doi: 10.1111/hae.12344. Epub 2014 Jan 13. Haemophilia. 2014. PMID: 24418368 Clinical Trial.

2

The need for speed in the management of haemophilia patients with inhibitors.

Salek SZ, Benson GM, Elezović I, Krenn V, Ljung RC, Morfini M, Remor E, Santagostino E, Sørensen B. Salek SZ, et al. Among authors: elezovic i. Haemophilia. 2011 Jan;17(1):95-102. doi: 10.1111/j.1365-2516.2010.02265.x. Haemophilia. 2011. PMID: 20398071

3

Comparison of two laboratory assays in monitoring the efficacy of different prophylaxis regimens for severe haemophilia.

Djunic I, Dopsaj V, Miljic P, Savic N, Milic N, Mitrovic M, Suvajdzic-Vukovic N, Tomin D, Elezovic I. Djunic I, et al. Among authors: elezovic i. Clin Lab. 2014;60(8):1325-31. doi: 10.7754/clin.lab.2013.130817. Clin Lab. 2014. PMID: 25185418

4

Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.

Lentz SR, Ehrenforth S, Karim FA, Matsushita T, Weldingh KN, Windyga J, Mahlangu JN; adept™2 investigators. Lentz SR, et al. J Thromb Haemost. 2014 Aug;12(8):1244-53. doi: 10.1111/jth.12634. Epub 2014 Jul 16. J Thromb Haemost. 2014. PMID: 24931322 Free PMC article. Clinical Trial.

5

Rationale for individualizing haemophilia care.

Sørensen B, Auerswald G, Benson G, Elezović I, Felder M, Lambert T, Morfini M, Remor E, Salaj P, Santagostino E, Šalek SZ, Ljung R. Sørensen B, et al. Among authors: elezovic i. Blood Coagul Fibrinolysis. 2015 Dec;26(8):849-57. doi: 10.1097/MBC.0000000000000225. Blood Coagul Fibrinolysis. 2015. PMID: 25396764 Review.

6

Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A.

Antovic JP, Mikovic D, Elezovic I, Holmström M, Wilkens M, Elfvinge P, Mahmoud Hourani Soutari N, Antovic A. Antovic JP, et al. Among authors: elezovic i. Thromb Haemost. 2012 Jul;108(1):21-31. doi: 10.1160/TH11-11-0811. Epub 2012 Apr 26. Thromb Haemost. 2012. PMID: 22534727

7

[Application of recombinant activated factor VII in treatment of intracranial haemorrhage in haemophilic patient with inhibitor].

Antić D, Elezović I, Sufajdzić N, Todorović M, Bila J, Mitrović M, Andjelkovic N. Antić D, et al. Among authors: elezovic i. Srp Arh Celok Lek. 2008 Sep;136 Suppl 3:218-21. doi: 10.2298/sarh08s3218a. Srp Arh Celok Lek. 2008. PMID: 19562872 Free article. Serbian.

8

On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients.

Mikovic D, Woodhams BJ, Holmström M, Elezovic I, Antovic A, Mobarrez F, Elfvinge P, Antovic JP. Mikovic D, et al. Among authors: elezovic i. Int J Lab Hematol. 2012 Feb;34(1):35-40. doi: 10.1111/j.1751-553X.2011.01349.x. Epub 2011 Jun 27. Int J Lab Hematol. 2012. PMID: 21707936

9

Acquired haemophilia syndrome: pathophysiology and therapy.

Elezović I. Elezović I. Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:64-8. doi: 10.2298/sarh10s1064e. Srp Arh Celok Lek. 2010. PMID: 20229686 Free article. Review.

10

[Acquired haemophilia A presenting in postpartum period--case report].

Mitrović-Vasiljević M, Antić D, Elezović I, Bila J, Todorović M. Mitrović-Vasiljević M, et al. Among authors: elezovic i. Srp Arh Celok Lek. 2008 Sep;136 Suppl 3:214-7. doi: 10.2298/sarh08s3214m. Srp Arh Celok Lek. 2008. PMID: 19562871 Free article. Serbian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

120 results

Search Page

Filters

My NCBI Filters

Search Results

120 results